Rethinking clinical delivery of adult stem cell therapies

Nature Biotechnology

Volumn 32, Issue 8, 2014, Pages 729-735

  Trainor, Nuala ^a   Pietak, Alexis ^a   Smith, Tim ^a  

^a Octane Biotechnology   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADULT STEM CELL; AUTOMATION; HUMAN; PROCEDURES; STEM CELL TRANSPLANTATION;

ADULT; ADULT STEM CELLS; AUTOMATION; HUMANS; STEM CELL TRANSPLANTATION;

EID: 84905723218     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt.2970     Document Type: Note

References (16)

1. Abdallah, B.M. & Kassem, M. Gene Ther. 15, 109-116 (2008).
2. Glotzbach, J.P. Curr. Probl. Surg. 48, 148-212 (2011).
3. Thomas, R. & Williams, D.J. Pharmatech 33, 74-79 (2009).
4. Halme, D.G. & Kessler, D. N. Engl. J. Med. 355, 1730-1735 (2006).
5. Huang, X.-P. et al. Circulation 122, 2419-2429 (2010).
6. Atoui, R. & Chiu, R. Stem Cells Trans. Med. 1, 200-205 (2012).
7. Porter, D.L. Hematology (Am. Soc. Hematol. Educ. Program) 2011, 292-298 (2011).
8. Hakimian, R. & Korn, D. J. Am. Med. Assoc. 292, 2500-2505 (2004).
9. Freeman, M. & Fuerst, M. J. Transl. Med. 10, 60 (2012).
10. Cosh, E., Girling, A., Lilford, R., McAteer, H. & Young, T. J. Commerc. Biotechnol. 13, 263-271 (2007).
11. O'Brien, J. Fortune http://fortune.com/2012/09/28/thegreat-stem-cell- dilemma/(8 October 2012).
12. Anonymous. Inbound Logistics 30, 75-76 (2010) http://www. inboundlogistics.com/cms/article/just-chillmoving-live-tissue/.
13. Denault, J., Coquet, A. & Dodelet, V. BioProcess Int. 6, 14-23 (2008).
14. Martin, I., Smith, T. & Wendt, D. Trends Biotechnol. 27, 495-502 (2009).
15. Santoro, R. et al. Biomaterials 31, 8946-8952 (2010).
16. US Food and Drug Administration. Guidance for Industry: Cell selection devices for point of care production of minimally manipulated autologous peripheral blood stem cells (PBSCs) http://www.fda. gov/OHRMS/DOCKETS/98fr/07d- 0290-gdl0001. pdf (US Department of Health and Human Services, 2007).